Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Study of ABC294640 Alone and in Combination With Hydroxychloroquine Sulfate in the Treatment of Patients With Advanced, Unresectable Intra-hepatic, Perihilar and Extra-Hepatic Cholangiocarcinoma

NCT03377179 is registered in ClinicalTrials.gov with RedHill Biopharma Limited as lead sponsor.

NCT NCT03377179
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03377179 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Study of ABC294640 Alone and in Combination With Hydroxychloroquine Sulfate in the Treatment of Patients With Advanced, Unresectable Intra-hepatic, Perihilar and Extra-Hepatic Cholangiocarcinoma
Lead sponsor
RedHill Biopharma Limited
Phase
Phase 2
Overall status
Completed
Start date
March 7, 2018
Completion date
June 21, 2022
Enrollment
65 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

cholangiocarcinoma, cholangiocarcinoma non-resectable, cholangiocarcinoma, extrahepatic, cholangiocarcinoma, intrahepatic, cholangiocarcinoma, perihilar